Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, acquisitions, and appointments, here’s a quick look at which stocks will be in focus in today's trade:
Avenue Supermarts, Aditya Birla Money, Droneacharya Aerial Innovations, Elecon Engineering Company, Emerald Finance, Jagsonpal Finance & Leasing, Nath Bio-Genes (India), and Astonea Labs will announce quarterly earnings scorecard on July 11.
Tata Consultancy Services Q1 (Consolidated YoY)
Profit grows 6% to Rs 12,760 crore Vs Rs 12,040 crore
Revenue increases 1.3% to Rs 63,437 crore Vs Rs 62,613 crore
Revenue declines 3.1% in constant currency
Operating income rises 0.5% to Rs 15,514 crore Vs Rs 15,442 crore
EBIT margin drops to 24.5% Vs 24.66%
Company announces dividend of Rs 11 per share
Total contract value (TCV) at $9.4 billion
Tata Elxsi Q1 (YoY)
Profit falls 21.6% to Rs 144.4 crore Vs Rs 184 crore
Revenue declines 3.7% to Rs 892.1 crore Vs Rs 926.5 crore
Indian Renewable Energy Development Agency IREDA Q1 (Consolidated YoY)
Profit tanks 35.7% to Rs 246.9 crore Vs Rs 383.7 crore
Revenue zooms 29% to Rs 1,947.6 crore Vs Rs 1,510.3 crore
Impairment on financial instruments stands at Rs 362.6 crore Vs writeback at Rs (30.04) crore
Anand Rathi Wealth Q1 (Consolidated YoY)
Profit surges 27.9% to Rs 93.9 crore Vs Rs 73.4 crore
Revenue grows 15.3% to Rs 274 crore Vs Rs 237.6 crore
Stocks to Watch
Rohit Jawa will step down as the Managing Director & Chief Executive Officer (MD & CEO) of the company, effective July 31. The Board has appointed Priya Nair as the MD & CEO for a term of five consecutive years, effective August 1.
IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI), and AbbVie have announced an exclusive licensing agreement for IGI’s lead investigational asset, ISB 2001. The drug was developed using IGI’s proprietary BEAT protein platform for oncology and autoimmune diseases.
Under the agreement, AbbVie will receive exclusive rights to develop, manufacture, and commercialize ISB 2001 across North America, Europe, Japan, and Greater China. Subject to regulatory clearance, IGI will receive an upfront payment of $700 million and is eligible to receive up to $1.225 billion in development, regulatory, and commercial milestone payments, along with tiered, double-digit royalties on net sales. Ichnos Glenmark Innovation (IGI) is a strategic alliance between Glenmark Pharma and Ichnos Sciences Inc.
The company has transferred its liquified petroleum gas (LPG) terminal, with cryogenic static storage capacity of 48,000 MT at Pipavav, to Aegis Vopak Terminals via a slump sale on a going concern basis for Rs 428.4 crore.
Zee Entertainment Enterprises failed to secure the required shareholder votes to raise funds by issuing warrants, blocking plans by the founding Goenka family to increase their stake in the broadcaster. Only 59.5% of participating shareholders supported the resolution—falling short of the 75% majority required for approval, according to a report by Reuters.
SBI Cards and Payment Services
Shantanu Srivastava has resigned as Chief Risk Officer of the company, effective October 6, 2025, due to personal reasons.
JB Chemicals & Pharmaceuticals
The Board has appointed Richa Arora as an Independent Director of the company.
The Board of Directors will meet on July 15 to consider a proposal for raising funds via the issuance of equity shares or other eligible securities.
To utilise its enhanced capacity and tap into growing global demand, the company is expanding its international presence by incorporating overseas subsidiaries in Poland, the United States of America, and Dubai, United Arab Emirates.
Shareholders have approved the re-appointment and remuneration of Pankaj Shah as Managing Director & CEO of the company for a term of three consecutive years, effective August 1, 2025.
The Board has approved the re-appointment of Ashwin Moodliar as Managing Director of the company for a period of two years, effective February 1, 2026. His current term ends on January 31, 2026.
Bulk Deals
APAC Company XXIII sold 1.78 crore units at Rs 388 per unit, valued at Rs 691.4 crore.
Jupiter City Developers (India) has acquired an additional 75 lakh shares at Rs 2.02 per share.
SME IPO Listing on July 11
Meta Infotech
Stocks Trade Ex-Dividend
Apollo Tyres
Artemis Medicare Services
Atul
Balkrishna Industries
Can Fin Homes
D-Link (India)
Geojit Financial Services
IDFC First Bank
Indus Finance
Jenburkt Pharmaceuticals
Kirloskar Ferrous Industries
Mahindra Logistics
Nilkamal
Nucleus Software Exports
PTL Enterprises
Roto Pumps
Shriram Finance
Sarthak Metals
Sobha
Toss The Coin
UPL
Xchanging Solutions
Zensar Technologies
Zydus Wellness
Stock Trades Ex-Date for Rights
JMJ Fintech
Stock Trades Ex-Bonus
Alkosign
Dynamic Cables
RIR Power Electronics
Roto Pumps
Stock in F&O ban
Hindustan Copper
RBL Bank
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
